Cargando…

Identification and Characterization of Besifovir-Resistant Hepatitis B Virus Isolated from a Chronic Hepatitis B Patient

Hepatitis B virus (HBV) is known to cause severe liver diseases such as acute or chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Chronic hepatitis B (CHB) infection is a major health problem with nearly 300 million individuals infected worldwide. Currently, nucleos(t)ide analogs (NA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jong Chul, Lee, Hye Young, Lee, Ah Ram, Dezhbord, Mehrangiz, Lee, Da Rae, Kim, Seong Ho, Won, Juhee, Park, Soree, Kim, Na Yeon, Shin, Jae Jin, Kim, Sang Gyune, Kim, Young Seok, Yoo, Jeong-Ju, Kim, Kyun-Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868672/ https://www.ncbi.nlm.nih.gov/pubmed/35203489 http://dx.doi.org/10.3390/biomedicines10020282

Ejemplares similares

Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir
por: Won, Juhee, et al.
Publicado: (2022)

Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System
por: Lee, Ah Ram, et al.
Publicado: (2022)

Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular Carcinoma
por: Park, Eun-Sook, et al.
Publicado: (2022)

Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B
por: Jung, Yeon Woo, et al.
Publicado: (2020)

Suppression of Hepatocyte Nuclear Factor 4 α by Long-term Infection of Hepatitis B Virus Contributes to Tumor Cell Proliferation
por: Park, Soree, et al.
Publicado: (2020)

Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial
por: Yim, Hyung Joon, et al.
Publicado: (2020)

Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial
por: Song, Do Seon, et al.
Publicado: (2021)

Effect of S267F variant of NTCP on the patients with chronic hepatitis B
por: Lee, Hye Won, et al.
Publicado: (2017)

The Roles of Ubiquitination in Pathogenesis of Influenza Virus Infection
por: Park, Eun-Sook, et al.
Publicado: (2022)

Distinctive HBV Replication Capacity and Susceptibility to Tenofovir Induced by a Polymerase Point Mutation in Hepatoma Cell Lines and Primary Human Hepatocytes
por: Lee, Ah Ram, et al.
Publicado: (2021)

Direct Detection of Drug-Resistant Hepatitis B Virus in Serum Using a Dendron-Modified Microarray
por: Kim, Doo Hyun, et al.
Publicado: (2018)

Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
por: Yoo, Jeong-Ju, et al.
Publicado: (2023)

Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients
por: Jang, Jae Young, et al.
Publicado: (2011)

Cell-permeable peptide nucleic acid antisense oligonucleotide platform targeting human betacoronaviruses
por: Park, Soree, et al.
Publicado: (2023)

Acute Hepatitis A-Induced Autoimmune Hepatitis: A Case Report and Literature Review
por: Jo, Hye In, et al.
Publicado: (2022)

Effect of tenofovir on renal function in patients with chronic hepatitis B
por: Jung, Woo Jin, et al.
Publicado: (2018)

Antiviral activity of interferon‐stimulated gene 20, as a putative repressor binding to hepatitis B virus enhancer II and core promoter
por: Park, Yong Kwang, et al.
Publicado: (2020)

Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus
por: Kim, Doo Hyun, et al.
Publicado: (2018)

Efficacy and Safety of Tenofovir Disoproxil Orotate in Chronic Hepatitis B Patients Previously Treated with Tenofovir Disoproxil Fumarate: Multicenter, Open-Label, Prospective Study
por: Chang, Young, et al.
Publicado: (2021)

Long-Term Outcomes and Dynamics of Mutants Associated with Lamivudine-Adefovir Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B
por: Kim, Jihyun, et al.
Publicado: (2015)

Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance
por: Ahn, Sung Hyun, et al.
Publicado: (2015)

Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study
por: Kwon, Oh Sang, et al.
Publicado: (2010)

Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B
por: Kim, Tae Hyung, et al.
Publicado: (2018)

Hepatitis B Core Antigen Expression in Hepatocytes Reflects Viral Response to Entecavir in Chronic Hepatitis B Patients
por: Lee, Jeong Guil, et al.
Publicado: (2013)

Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients
por: Lee, Han Ah, et al.
Publicado: (2022)

Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
por: Lim, Jae Hee, et al.
Publicado: (2011)

Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy
por: Seo, Yeon Seok, et al.
Publicado: (2016)

Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: A multicenter study
por: Jun, Baek Gyu, et al.
Publicado: (2018)

The Diagnostic Accuracy of LOGIQ S8 and E9 Shear Wave Elastography for Staging Hepatic Fibrosis, in Comparison with Transient Elastography
por: Yoo, Jeong-Ju, et al.
Publicado: (2021)

Hepatic STAMP2 decreases hepatitis B virus X protein-associated metabolic deregulation
por: Kim, Hye Young, et al.
Publicado: (2012)

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
por: Lee, Yun Bin, et al.
Publicado: (2019)

Hepatocyte Growth Factor-Dependent Antiviral Activity of Activated cdc42-Associated Kinase 1 Against Hepatitis B Virus
por: Lee, Hye Won, et al.
Publicado: (2021)

A Case of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Treated by Hepatic Arterial Infusion Chemotherapy and Radiotherapy
por: Lee, Jin Yong, et al.
Publicado: (2020)

Efficacy of Initial Treatment with Clevudine in Naive Patients with Chronic Hepatitis B
por: Yang, Hyeon Woong, et al.
Publicado: (2010)

Effect of hepato-toxins in the acceleration of hepatic fibrosis in hepatitis B mice
por: Poilil Surendran, Suchithra, et al.
Publicado: (2020)

T cell subsets in chronic hepatitis B and the effect of prednisolone withdrawal and interferon alpha-2b
por: Im, Euyi Hyeok, et al.
Publicado: (1999)

Elecsys Hepatitis B Surface Antigen Quantitative Assay: Performance Evaluation and Correlation with Hepatitis B Virus DNA during 96 Weeks of Follow-up in Chronic Hepatitis B Patients
por: Lee, Hyun Ji, et al.
Publicado: (2012)

Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance
por: Lee, Hyun Woong, et al.
Publicado: (2020)

Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
por: Yim, Sun Young, et al.
Publicado: (2017)

Extremely rare case of necrotizing gastritis in a patient with autoimmune hepatitis: A case report
por: Moon, Seung Ki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_73a9iv33qr8njtdsu8daeaeqsd